Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Predialysis Care
Challenges and opportunities
David C Mendelssohn
Road map
Initiation of Dialysis
Suboptimal starts
Optimizing Care
Challenges and opportunities
Lets focus on Canadian
data
1) It is of interest to look at places other
than the USA
2) I know Canada best
3) Unfortunately, there is not much data
from eastern Europe
4) Lessons learned are generalizable to
other places
Why the Interest in Pre-ESRD
Care?
Death rates and sickness on dialysis remains
unacceptably high
Attention to dialysis prescription and other
dialysis related risk factors has only changed
this to a small degree
Many problems leading to sickness and death
on dialysis begin well before ESRD, and may be
modifiable
Pre-ESRD care is often less than ideal, and
dialysis may be started in a suboptimal manner
Decreased
Optimal ? morbidity
pre - ESRD and mortality
care on dialysis
A) Nephro-
logist
A) Primary Early
alone A) Conservativ
B) Multi- e
care B) Dialysis
disciplinar
B) No care Late C) Transplant
y
predialysis
Non team
Referral
Referral Preparation
Care in the Community
Recognition of CKD
Workup of CKD
Consequences
Anemia
Metabolic acidosis
Hyperphosphatemia
Hypoalbuminemia
HTN, volume overload
Low prevalence of AVF as initial dialysis access
Low rate of initiation of home dialysis
Delayed referral to transplant
Increased hospitalization rate
Higher cost of dialysis initiation
Increased 1 yr mortality
Approach to diagnosis
Specific therapy
Education
Modality selection
Tasks Unplanned
start
Late Not Emergent
Referral Comp Inpatient
CVC
-leted
Suboptimal starts
Care in the
community
Referral Thresholds
Consider how you would respond to the following abnormal lab tests
120-150
151-300
Internist
Nephrologist
301-600
Urologist
No Referral
601-900
>901
SBP 150
DBP 80
ACEI or ARB 44%
Diuretic 50%
# of BP agents 1.9
Establish diagnosis
Consider biopsy
}
Diagnosis
Reversible factors Treat CV risk factors, Prepare
associated conditions and For
slow rate of progression
towards ESRD
ESRD
Time
Preparation for ESRD
1) Patient education
2) Modality choice
- include no dialysis & trial of dialysis options
3) Transplant consideration
- Is preemptive possible?
4) Dialysis access creation
5) Smooth entry into ESRD
program
All this takes time, especially vascular access
Late referral Early referral
No patient choice Informed patient choice
HD
HD home
home TX TX
5) Timely initiation
20
Encourage home Transplant
dialysis (PD and
(ml/min)
15
home HD) and live PD
donor pre-
10 emptive Hemodialysis
transplant if
5 suitable
Time on
0
Initiation of Dialysis Dialysis
Mendelssohn DC and Pierratos A. PDI 22; 5-8: 2002
Canadian 8 Centre CKD Study
(Levin LVH study)
PRDC No PRDC P
N 42 21
Graft 2.4% 0 NS
Goldstein MB et al, AJKD 44; 706-714: 2004
Multidisciplinary vs standard
care
PRDC No PRDC P
Albumin 36 33 <0.01
7 hospital days/pt/year
90
2% death rate at one year
80
PRDC
70
Standard
60
70 hospital days/pt/year
50 23% death rate at one year
40
0 10 20 30 40 50 60
Days
Standard MDC P
Hb 90 102 <0.0001
90
MDC
80
Standard
70
60
0 100 200 300 400 500 600 700 800 900
Days
Level 1 HD $21311
Level 2 HD $31122
CAPD $26725
APD $30774
15 centres
Age 59 58 63
GFR (MDRD) 8.0 8.1 7.7
Sx 3 3 3.5
Albumin (g/L) 32.7 33.7 30.6
Hb (g/L) 92.6 94.3 89.5
Tasks Unplanned
start
Late Not Emergent
Referral Comp Inpatient
CVC
-leted
Comp Planned
start
Early -letion Elective
referral of Outpatient
AVF
tasks
1) Patient related delay
2) Acute on CKD
3) Suboptimal care
4) No chronic HD spot
Tasks Unplanned
start
Not Emergent
Late
Referral Comp Inpatient
CVC
-leted
Problems and Solutions
October 2006
www.csnscn.ca
Excessive referral
Early referral
Non-referral
Late referral
Inappropriate referral
Timely referral
Pragmatic Balance
1.00
1.00
Adjusted by age,
race, gender,
0.99
0.99 diabetes
0.98
0.98
RightStart
Survival
Cum Survival
0.97
0.97
Cum
0.96
0.96
P<0.001 by Cox
0.95
0.95 Control Log-rank, Breslow,
and Tarone-Ware
0.94
0.94
tests at 90 day
exposure levels.
0.93
0.93
00 20
20 40
40 60
60 80
80 100
100
risk_days_90
risk_days_90
Survival Curve, 11stst 365
Survival Curve, 365 Days
Days
Adjusted
Adjusted Cox-proportional
Cox-proportional hazards
hazards regression
regression model
model
Survival
Survival Function
Function for
for patterns
patterns 11 -- 22
1.00
1.00
Adjusted by age,
race, gender,
diabetes
0.95
0.95
RightStart
Survival
Cum Survival
0.90
0.90
Cum
0.85
0.85
Control P<0.001 by Cox Log-
rank, Breslow, and
Tarone-Ware tests
at 90, 180, and 365
0.80
0.80 day exposure levels.
00 100
100 200
200 300
300 400
400
risk_days_365
risk_days_365
A Prospective Randomized study of
Cased Managed Initiation of HD